Lawmakers target new high-priced drug

Published October 20, 2016 6:27pm ET



Lawmakers are getting angry over a new price hike for a drug, this time targeting a cancer drug whose price was raised four times this year alone.

Former presidential candidate Sen. Bernie Sanders, I-Vt., and Rep. Elijah Cummings, D-Md., sent a letter Thursday to Ariad Pharmaceuticals for answers about Iclusig, which treats a bone marrow cancer that makes too many white blood cells. Sanders and Cummings, who have targeted high-priced drugs, said Ariad has added more than $80,000 to the drug’s already high price tag this year.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.